medica glp-1 coverage for some popular medications is set to go away in January GLP-1 Trends: Access & Shortages,

Results Thirteen RCTs with 13,761 participants were analyzed

Whilst transdermal patch formulations represent an area of ongoing pharmaceutical research, no GLP-1 patches are currently licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) or approved by the National Institute for Health and Care Excellence (NICE) for use in the United Kingdom

Ask about cold chain maintenance

Avoid using lotions, oils, moisturisers, or alcohol-based products on the application site, as these may interfere with patch adhesion or drug absorption

Neither approach helps you make an actual decision

A month following the procedure, those on tirzepatide had a 54% lower risk of experiencing major cardiovascular events like heart attack than dulaglutide users, the researchers found